Nelarabine (Intravenous Route)


Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Nelarabine (Intravenous Route)

Drug Information provided by: Micromedex

US Brand Names

  • Arranon

Description

Nelarabine belongs to the group of medicines called antineoplastics. It is used to treat specific types of cancer called T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) .

Nelarabine interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected by nelarabine, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects may not be serious, but may cause concern .

Before you begin treatment with nelarabine, you and your doctor should talk about the good this medicine will do as well as the possible risks of using it. This medicine is usually given to patients who have already used at least two other cancer medicines first .

Nelarabine is to be administered only by or under the supervision of your doctor .

This medicine is available only with your doctor's prescription .

Before Using
DR602407 Portions of this document last updated: Nov. 1, 2011

Source: Drug Information provided by: Micromedex

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger